About Biametrics
Biametrics is a Healthcare company based in Tubingen (Germany) founded in 2010. It operates as a label-free biosensor technology is provided for biomolecular interaction analysis. Biametrics has raised $4.33 million across 3 funding rounds from investors including KfW, MBG and LBBW Venture Capital. Biametrics offers products and services including Antibodies, Assay Kits, Enzymes, and Elisa Kits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is Biametrics GmbH. Its competitors include Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
Biametrics was founded in 2010 in Tubingen, Germany, where label-free analytical systems are developed and marketed for life science applications. Patented biosensor technology is utilized, incorporating detection methods, surface chemistry, and assay development for time-resolved biomolecular interaction analysis. Products include the b-screen device for microarray uses and the b-portable device for point-of-need analysis. Operations focus on innovative solutions in the biotechnology sector.
- Headquarters Tubingen, Germany
- SectorsHealthcare
- Email••••••••
- Website biametrics.com
- Social LinkedIn
- Legal Name Biametrics Gmbh
- Total Equity Funding$4.33M (USD)
in 3 rounds
- Latest Funding Round$3.51M (USD), Series A
Sep 2015
- InvestorsKfW
& 4 more
Products & Services of Biametrics
Biametrics offers a comprehensive portfolio of products and services, including Antibodies, Assay Kits, Enzymes, and Elisa Kits.
Reagents for detecting proteins in research experiments.
Kits for performing laboratory assays and tests.
Proteins that catalyze reactions in scientific studies.
Tools for enzyme-linked immunosorbent assays in research.
Funding Insights of Biametrics
Biametrics has successfully raised a total of $4.33M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.51 million completed in September 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.33M
- Total Rounds 3
- Last Round Series A — $3.51M
- First Round $816,570
(Sep 2010)
- Investors Count 5
All 3 funding rounds of Biametrics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
5 investors in total: 5 institutional.
Investors in Biametrics
Biametrics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include KfW, MBG and LBBW Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on small and mid-sized companies | – | mbg.de | Stuttgart, Germany | |
Early-stage VC firm investing in smart & deep-tech, fin-tech and life science & health-tech sectors | – | lbbwvc.de | Stuttgart, Germany | |
Early-stage investments are made in high-tech startups by HTGF. | – | htgf.de | Bonn, Germany | |
Consumer and SME loans are provided across Germany. | 1948 | kfw.de | Frankfurt Am Main, Germany | |
- | – | seedfonds-bw.de | - |
Investor details for Biametrics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biametrics
3 dated milestones of Biametrics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Biametrics is founded.
- Funding First funding round of $817K.
- Funding Latest funding round, Series A, of $3.5M.
Competitors of Biametrics
Biametrics has 9 listed competitors in our database, 5 of them funded. They include Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| abclonal.com | 2006 | Woburn, United States | $281.25M | – | Developer of protein and peptide reagents and kits for cell and molecular biology research | |
| seracare.com | 1984 | Milford, United States | – | – | Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability |
Detailed competitors of Biametrics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Biametrics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biametrics
Complete news archive for Biametrics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biametrics
Biametrics was founded in 2010.
Biametrics is headquartered in Tubingen, Germany. It is registered at Tubingen, Baden-wurttemberg, Germany.
Biametrics is a funded company, having raised a total of $4.33M across 3 funding rounds to date. The company's 1st funding round was a Seed of $816.57K, raised on Sep 2010.
Biametrics was founded in 2010 in Tubingen, Germany, where label-free analytical systems are developed and marketed for life science applications. Patented biosensor technology is utilized, incorporating detection methods, surface chemistry, and assay development for time-resolved biomolecular interaction analysis. Products include the b-screen device for microarray uses and the b-portable device for point-of-need analysis. Operations focus on innovative solutions in the biotechnology sector.
Biametrics's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Biametrics offers Antibodies, Assay Kits, Enzymes, and Elisa Kits.
Biametrics has 5 investors. Key investors include KfW, MBG, LBBW Venture Capital, High-Tech Gründerfonds, and Seedfonds BW.
Biametrics operates through Biametrics Gmbh.